Progranulin in neurodegenerative dementia

Area of Science:

• Neuroscience
• Genetics
• Pathology

Background:

• Neurodegenerative dementias involve a lack of protective factors.
• Progranulin (PGRN) is a neurotrophic factor with neuroprotective roles.
• Mutations in the PGRN gene (GRN) are implicated in FTLD and AD.

Purpose of the Study:

• To summarize the role of PGRN deficiency and its products in dementia pathogenesis.
• To highlight PGRN as a therapeutic target for neurodegeneration.

Main Methods:

• Literature review and summary of existing research on PGRN and dementia.
• Analysis of PGRN's involvement in tau and TDP-43 aggregation, Aβ production, neuroinflammation, lysosomal dysfunction, neuronal death, and synaptic deficits.

Main Results:

• PGRN deficiency contributes to key pathological hallmarks of dementia.
• PGRN's neuroprotective functions are crucial for neuronal health.
• Therapeutic strategies targeting PGRN are under development.

Conclusions:

• PGRN plays a critical role in preventing neurodegeneration.
• Targeting PGRN presents a viable therapeutic avenue for dementia treatment.